Table 1. Oligonucleotides used in this study.

Oligonucleotide	Sequence (5’–3’)
1	GACG A A T T CTACAATTTCAGGTGGCAC
2	GGTG A A T T CGTAAACTTGGTCTGACAG
3	CCGATTAC A T A T GGAAGCAGTAGCTTATTC
4	GAC T C G A GATCATCAGATTCAACCTCG
5	TTCAG G A T C CAGGATTATGTGTATTGCG
6	CCGCA A G C T TTTAAGTTTCTGACCCTTTCC
7	GAGTA C T A G TGAAAAAGCAGGATTTGAGG
8	CCAAG G A T C CGAATAAGCTACTGCTTCC
9	CGGTCG G A T C CAATAAAGATAATCATC
10	ATTCG G A T C CTTAATAGTGATCTTTTGCAG
11	CGGGA C T A G TTAGAAATAAATAAGGGGT
12	CAAAAAGAGATTACGACTCTATGCAAGAAACG
13	CGTTTCTTGCATAGAGTCGTAATCTTTTTTG
14	CGCGGG A A T T CTAGAAATAAATAAGGGGT
15	GCACTAAATCATCACTTTCGGGAAAG
16	GAGTG A A T T CGAAAAAGCAGGATTTGAGG
17	ATCG G A T C CGTAATACGCGTAAC
18	CCGCA A G C T TGCTCATGCCAATAAAGATAATC
19	[BTN]AGCAACTAAAGCAGAAGTACGGC
20	TCATATAACTACGTAAATTTTGGCGG
21	[BTN]TTCCGCCAAAATTTACGTAGTTA
22	TTGCATAGAATCATAATCTCTTTTTGA

Restriction sites or introduced mutations are underlined.